On Thursday, Weight Watchers International, Inc. (NYSE:WTW)’s shares declined -12.71% to $4.09.
That was the headline on Briefing.com after alarm bells were tripped over Weight Watchers’ ( WTW) 10% share price decline in Thursday morning trading. But here is something you may not know.
Despite having a stock that is down nearly 50% since first quarter earnings, 80% over the past 12 months, and 84% year-to-date, Weight Watchers stock is still … too expensive to buy.
It may not look that way at first glance. According to data from S&P Capital IQ, Weight Watchers shares presently cost less than three times trailing earnings. And even if earnings are weak going forward, the stock sells for well under 10 times forward earnings estimates, which does not sound all that expensive.
But that does not paint a complete picture. First off, analyst estimates for long-term earnings growth at Weight Watchers presently hover around 2% annually over the next five years. So even at less than three times earnings, the stock already sells for a PEG ratio of 1.5 — value investors ordinarily target stocks selling for a price-to-earnings-to-growth ratio of one or less.
Weight Watchers International, Inc. provides weight management services worldwide. The company operates through North America, United Kingdom, Continental Europe, and Other segments. It offers a range of products and services comprising nutritional, exercise, and behavioral tools and approaches. The company also provides various products, including bars, snacks, cookbooks, food, and restaurant guides with PointsPlus values, Weight Watchers magazines, PointsPlus calculators, and fitness kits, as well as ActiveLink products.
Abbott Laboratories(NYSE:ABT)’s shares dropped -0.22% to $49.41.
The board of directors of Abbott (ABT) declared a quarterly common dividend of 24 cents per share.
This marks the 366th successive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2015, to shareholders of record at the close of business on July 15, 2015.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
At the end of Thursday’s trade, Public Service Enterprise Group Inc. (NYSE:PEG)‘s shares surged 1.24.% to $39.94.
Public Service Enterprise Group Inc. (PEG) through its wholly-owned subsidiary PSEG Fossil, has acquired the 755-MW Keys Energy Center project from Genesis Power, LLC and an energy-focused private equity fund managed by Ares EIF Management, LLC. PSEG Power plans to rename the facility the PSEG Keys Energy Center (KEC).
PSEG Power – an independent power producer and partner of PSEG – anticipates to start construction of the natural gas-fired, combined-cycle plant in 2015. The plant, which represents an investment of $825 - $875 million, is targeted to be accomplished and supplying needed capacity and energy to the state of Maryland and region in 2018. The project was bid into and cleared the PJM capacity auction in May 2014.
PSEG Fossil will oversee construction, operate and maintain the combined-cycle plant. SNC - Lavalin Constructors Inc. is the designated engineering, procurement and construction contractor. The combined-cycle plant will use state-of-the-art generating technology, counting a full complement of emissions controls and run on clean, efficient natural gas. The plant will generate about 700 jobs during the two-year construction phase. More than 20 permanent jobs will be created to run the new plant once it becomes operational.
Public Service Enterprise Group Incorporated, through its auxiliaries, operates as an energy company primarily in the northeastern and Mid Atlantic United States. The company operates nuclear, coal, gas, oil-fired, and renewable generation facilities with a generation capacity of about 13,146 megawatts. It sells electricity, natural gas, emissions credits, and a series of energy-related products that are used to optimize the operation of the energy grid.
Cyberark Software Ltd (NASDAQ:CYBR), ended its Thursday’s trading session with -3.04% loss, and closed at $60.38.
CyberArk ( CYBR), the company that protects organizations from cyber attacks that have made their way inside the network perimeter, recently declared details of its forthcoming webinar, “30-Day Cybersecurity Sprint: Tightening Privileged User Policies.” The session will outline the cybersecurity initiative from the White House and U.S. Federal CIO Tony Scott, and explore how agencies can better protect sensitive information and assets, and make it more difficult for hackers to gain access to federal systems.
CyberArk Software Ltd. develops, markets, and sells software-based IT security solutions that protect organizations from cyber attacks in the United States and internationally. The company offers privileged account security solution to secure, manage, and monitor privileged account access and activities. Its privileged account security solution comprises of Enterprise Password Vault that provides a tool to manage and protect physical, virtual, or cloud-based assets; SSH Key Manager to store, rotate, and control access to SSH keys for preventing unauthorized access to privileged accounts; Privileged Session Manager that protects servers, applications, databases, and hypervisors from malware; and Privileged Threat Analytics that profiles and analyzes individual privileged user behavior and creates prioritized alerts when abnormal activity is detected.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
